Abstract:Enterovirus 71 (EV71) is the major pathogens of human hand, foot, and mouth disease (HFMD). EV71 efficiently escapes innate immunity responses of the host to cause infection. At present, no effective antiviral drugs for EV71 are available. Anemoside B4 (B4) is a natural saponin isolated from the roots of Pulsatilla chinensis (Bunge) Regel. P. chinensis extracts that shows a wide variety of biological activities. In this study, we investigated the antiviral activities of B4 against EV71 both in cell culture and in suckling mice. We showed that B4 (12.5–200 μM) dose dependently increased the viability of EV71-infected RD cells with an IC50 value of 24.95 ± 0.05 μM against EV71. The antiviral activity of B4 was associated with enhanced interferon (IFN)-β response, since knockdown of IFN-β abolished its antiviral activity. We also confirmed that the enhanced IFN response was mediated via activation of retinoic acid-inducible gene I (RIG-I) like receptors (RLRs) pathway, and it was executed by upregulation of 14-3-3 protein, which disrupted the interaction between yes-associated protein (YAP) and interferon regulatory factor 3 (IRF3). By using amino acids in cell culture (SILAC)-based proteomics profiling, we identified the Hippo pathway as the top-ranking functional cluster in B4-treated EV71-infected cells. In vivo experiments were conducted in suckling mice (2-day-old) infected with EV71 and subsequently B4 (200 mg · kg−1 · d−1, i.p.) was administered for 16 days. We showed that B4 administration effectively suppressed EV71 replication and improved muscle inflammation and limb activity. Meanwhile, B4 administration regulated the expressions of HFMD biomarkers IL-10 and IFN-γ, attenuating complications of EV71 infection. Collectively, our results suggest that B4 could enhance the antiviral effect of IFN-β by orchestrating Hippo and RLRs pathway, and B4 would be a potential lead compound for developing an anti-EV71 drug.

Antiviral Effect of Emodin on Coxsakievirus B4 in vitro

Inhibition of the Replication of Hepatitis B Virus in Vitro by Emodin.

[Inhibitory effects of emodin on proliferation of rat vascular smooth muscle cell induced by angiotensin II].

Effect of Emodin on Coxsackievirus B3m-Mediated Encephalitis in Hand, Foot, and Mouth Disease by Inhibiting Toll-Like Receptor 3 Pathway In Vitro and In Vivo

Promising Role of Emodin as Therapeutics to Against Viral Infections

Inhibitory Effect of Emodin and Astragalus Polysaccharideon the Replication of HBV

Emodin as an Inhibitor of PRV Infection In Vitro and In Vivo

Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma

Study on In-vitro Antiviral Activity of Seaweed Extracts Obtained by Different Methods

[The Suppressive Effect of MiR-490 on Coxsackievirus B3 Replication].

Chaetocin significantly inhibits coxsackievirus B3 replication in vitro

Inhibition on hepatitis B virus by emodin and astragalus polysaccharides in vitro

Antiviral activity of an isatin derivative via induction of PERK-Nrf2-mediated suppression of cap-independent translation.

Anti-BVDV Activity of Traditional Chinese Medicine Monomers Targeting NS5B (RNA-Dependent RNA Polymerase) In Vitro and In Vivo

A Cpg Oligodeoxynucleotide Inducing Anti-Coxsackie B3 Virus Activity In Human Peripheral Blood Mononuclear Cells

Umifenovir Effectively Inhibits IL-10 Dependent Persistent Coxsackie B4 Virus Infection

Anemoside B4 inhibits enterovirus 71 propagation in mice through upregulating 14-3-3 expression and type I interferon responses

Emodin modulates the host antiviral response of fish against spring viremia of carp virus infection

The Evaluation of an Immunoperoxidase Assay Applicable in Antiviral Drug Screening.

Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis

Identification of Novel Bisamide-Decorated Benzotriazole Derivatives as Anti-Phytopathogenic Virus Agents: Bioactivity Evaluation and Computational Simulation